View Financial HealthBespoke Extracts 배당 및 자사주 매입배당 기준 점검 0/6Bespoke Extracts 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.공시 • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.공시 • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.공시 • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.공시 • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.공시 • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.공시 • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.공시 • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.공시 • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.공시 • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.공시 • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 BSPK 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: BSPK 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Bespoke Extracts 배당 수익률 vs 시장BSPK의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (BSPK)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.3%업계 평균 (Pharmaceuticals)2.2%분석가 예측 (BSPK) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 BSPK 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 BSPK 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 BSPK 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: BSPK 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/18 22:54종가2026/05/06 00:00수익2025/09/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Bespoke Extracts, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
공시 • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.
공시 • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.
공시 • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.
공시 • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.
공시 • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.
공시 • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.
공시 • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.
공시 • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.
공시 • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.
공시 • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.